Stewart, Mark D

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

Stewart, M. D., Merino Vega, D., Arend, R. C., Baden, J. F., Barbash, O., Beaubier, N., Collins, G., French, T., Ghahramani, N., Hinson, P., et al. (2022) · The Oncologist

PARP inhibition in cancer therapyBRCA gene mutations in cancer

Cited by 240

The heparanase/syndecan‐1 axis in cancer: mechanisms and therapies

Ramani, V. C., Purushothaman, A., Stewart, M. D., Thompson, C. A., Vlodavsky, I., Au, J. L., & Sanderson, R. D. (2013) · The FEBS Journal

Proteoglycans and glycosaminoglycans researchProtease and Inhibitor Mechanisms

Cited by 189

Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium

Hadd, A. G., Silvestro, A., McKelvey, B. A., Baden, J., Bormann Chung, C., Brown, B., Cruz‐Guilloty, F., Godsey, J., Jones, G., Lin, C. J., et al. (2025) · Clinical and Translational Science

Cancer Genomics and DiagnosticsAcute Lymphoblastic Leukemia research

Cited by 14